Tar DNA-binding protein 43 (TDP-43) is an RNA-binding protein normally localized to the nucleus of cells, where it elicits functions related to RNA metabolism such as transcriptional regulation and alternative splicing. In amyotrophic lateral sclerosis, TDP-43 is mislocalized from the nucleus to the cytoplasm of diseased motor neurons, forming ubiquitinated inclusions. Although mutations in the gene encoding TDP-43, TARDBP, are found in amyotrophic lateral sclerosis, these are rare. However, TDP-43 pathology is common to over 95% of amyotrophic lateral sclerosis cases, suggesting that abnormalities of TDP-43 play an active role in disease pathogenesis. It is our hypothesis that a loss of TDP-43 from the nucleus of affected motor neurons in amyotrophic lateral sclerosis will lead to changes in RNA processing and expression. Identifying these changes could uncover molecular pathways that underpin motor neuron degeneration. Here we have used translating ribosome affinity purification coupled with microarray analysis to identify the mRNAs being actively translated in motor neurons of mutant TDP-43 A315T mice compared to age-matched non-transgenic littermates. No significant changes were found at 5 months (presymptomatic) of age, but at 10 months (symptomatic) the translational profile revealed significant changes in genes involved in RNA metabolic process, immune response and cell cycle regulation. Of 28 differentially expressed genes, seven had a 52-fold change; four were validated by immunofluorescence labelling of motor neurons in TDP-43 A315T mice, and two of these were confirmed by immunohistochemistry in amyotrophic lateral sclerosis cases. Both of these identified genes, DDX58 and MTHFSD, are RNA-binding proteins, and we show that TDP-43 binds to their respective mRNAs and we identify MTHFSD as a novel component of stress granules. This discovery-based approach has for the first time revealed translational changes in motor neurons of a TDP-43 mouse model, identifying DDX58 and MTHFSD as two TDP-43 targets that are misregulated in amyotrophic lateral sclerosis.
Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive loss of upper and lower motor neurons leading to fatal paralysis within 3-5 years from diagnosis. Most instances of ALS are sporadic, although $5-10% of patients have a familial history. Several ALS-causative mutations have been found in a number of genes including SOD1, TARDBP, FUS/TLS, OPTN, UBQLN2, hnRNPA2B1, hnRNPA1, C9orf72, MATR3, VCP and TBK1, which have alluded to common pathways including impairments in RNA metabolism, protein homeostasis, and neuroinflammation (Ling et al., 2013; Johnson et al., 2014; Renton et al., 2014; Freischmidt et al., 2015) . Despite the heterogeneous aetiology of ALS, $90% of all cases exhibit depletion of TAR DNA-binding protein encoded by TARDBP) from the nucleus to the cytoplasm where it forms ubiquitinated inclusions in affected motor neurons and glial cells (Arai et al., 2006; Neumann et al., 2006; Dickson et al., 2007; Geser et al., 2008; McCluskey et al., 2009) .
TDP-43 is a heterogeneous ribonuclear protein (hnRNP) that is involved in multiple steps of RNA processing including transcriptional repression, alternative splicing, microRNA biogenesis, mRNA transport and translation (Arai et al., 2006; Neumann et al., 2006; Dickson et al., 2007; Geser et al., 2008; McCluskey et al., 2009; Ling et al., 2013) . It is also a component of stress granules, a cellular protection mechanism and TDP-43 levels can modulate stress granule formation, size and disassembly (Liu-Yescevitz et al., 2010; McDonald et al., 2011; Dewey et al., 2012) . Loss of normal TDP-43 function would therefore have potentially critical consequences in causing misregulation of RNA processing. Indeed, misregulated RNA processing as a convergent pathogenic mechanism in ALS is also supported by the finding of a number of causal mutations in RNA recognition motif (RRM)-containing proteins including TDP-43, FUS/TLS, hnRNPA2B1, hnRNPA1 and MATR3 (Sreedharan et al., 2008; Kwiatkowski et al., 2009; Kim et al., 2013; Johnson et al., 2014) , and sequestration of RNA binding proteins in RNA foci by G 4 C 2 repeat expansion in C9orf72 (DeJesusHernandez et al., 2011; Renton et al., 2011) . However, the role(s) of abnormal TDP-43 in ALS pathogenesis remains to be fully elucidated.
We are working on the hypothesis that identifying the changes in RNA metabolism that occur as a consequence of abnormalities in TDP-43 will uncover molecular pathways that underpin the neurodegenerative mechanism in ALS. Large-scale gene expression data are useful to delineate specific mechanisms in complex diseases. Several published gene expression studies in animal and cell models of ALS and patient CNS tissue have found many genes associated with disease pathogenesis (reviewed in CooperKnock et al., 2012); however, few candidate genes have been validated in diseased tissues (Kudo et al., 2010; Lagier-Tourenne et al., 2012) .
Here, we have used an innovative technique-translating ribosome affinity purification (TRAP)-coupled with microarray analysis to investigate the translatome in motor neurons of a TDP-43 A315T transgenic mouse model that develops age-dependent neurodegeneration (Doyle et al., 2008; Heiman et al., 2008; Swarup et al., 2011) . This method, as applied here, depends on the usage of enhanced green fluorescent protein (EGFP)-tagged L10a polysomal protein specifically expressed under control of the choline acetyltransferase (Chat) promoter to facilitate isolation of polysomes from spinal motor neurons. TRAP was performed on 5-month (presymptomatic) and 10-month-old (symptomatic) A315T transgenic mice and non-transgenic control littermates (Swarup et al., 2011) . The most significant changes were observed in motor neurons of 10-month-old TDP-43 A315T mice, with an over-representation of genes involved in RNA metabolic processes, immune response and regulation of cell cycle. Seven genes exhibited a 52-fold expression, four of which, Ddx58 and Ccl4 (upregulated), and Prickle4 and Mthfsd (downregulated), were validated by immunofluorescence labelling of motor neurons in TDP-43 A315T mouse spinal cord. Interestingly, these genes are associated with pathways already linked with ALS, including neuroinflammation and stress granules (Ferraiuolo et al., 2011; Li et al., 2013) . We also validated DDX58 and MTHFSD, both of which are RNA binding proteins, in motor neurons in ALS spinal cord. DDX58 showed an increased cytoplasmic immunoreactivity in motor neurons and MTHFSD showed reduced nuclear labelling in ALS cases compared to controls, validating our TRAP findings. Furthermore, we show that MTHFSD and DDX58 are RNA targets of TDP-43, supporting that abnormalities of TDP-43 would lead to deregulation of these genes. Finally, we identify MTHFSD as a novel stress granule marker. Collectively, our findings have demonstrated the utility of TRAP in identifying motor neuron specific changes in translating-mRNA expression in TDP-43 A315T mice, identifying two novel genes that are misregulated in ALS.
Materials and methods

Patient information, tissue collection and consent
Body disease, where there is no disease in the spinal cord and as such act as controls for ALS).
Mouse husbandry
All protocols were conducted in accordance with the Canadian Council on Animal Care and approved by the University of Toronto Animal Care Committee. The TDP-43
A315T transgenic mice express a bacterial artificial chromosome (BAC) of human TARDBP including its promoter on a C3H Â C57BL/6 background and develop a motor phenotype at $10 months of age (Swarup et al., 2011) . The ChatbacTRAP (DW167) mouse line, in which the EGFPL10a transgene is under control of the Chat promoter for expression in spinal motor neurons (Doyle et al., 2008; Heiman et al., 2008) , was re-derived on a C57BL/6 mouse background by the Jackson Laboratory (Bar Harbor, Maine) and bred to homozygosity to simplify breeding. Homozygous ChatbacTRAP mice were crossed with hemizygous TDP-43 A315T mice to generate ChatbacTRAP Â TDP-43
A315T
mice and ChatbacTRAP only littermates as controls.
Breeding, weaning at 3 weeks and genotyping, was performed according to established protocols (Doyle et al., 2008; Heiman et al., 2008; Swarup et al., 2011) . The following primers were used for genotyping: EGFP forward, 5'-CCTACGGCGTGCA GTGCTTCAGC-3', reverse 5'-CGGCGAGCTGCACGCTGC GTCTC-3'; b-actin (Actb) forward, 5'-CAATAGTGATGACC TGGCCGT-3', reverse, 5'-AGAGGGAAATCGTGCGTGAC-3'; TDP-43 A315T forward, 5'-CTCTTTGTGGAGAGGAC-3', reverse, 5'-GGATTAATGCTGAACGT-3'.
TRAP purification, quantification and amplification of mRNA samples Mice were euthanized at 5 or 10 months of age in a CO 2 chamber and spinal cords from three animals of each genotype, ChatbacTRAP Â TDP-43 A315T and ChatbacTRAP, were dissected and combined for each immunopurification of EGFP-L10a, with n = 4 immunopurifications per genotype. Purification of translating mRNAs from cholinergic spinal cord neurons was carried out as previously described (Heiman et al., , 2014 Microarray quality control, normalization and expression analysis
Data for the gene expression set were checked for overall quality using R (v2.14.1) with the Bioconductor framework package installed. Genespring v12.1 was used for subsequent analyses. The data were normalized using a standard (for dual colour Agilent arrays) spatial detrending normalization. All data analysis and visualization was performed on log2-transformed data. Only probes that were in the upper 80th percentile of the distribution of intensities in three of the four replicates for any of the one of two experimental groups was allowed to pass through this filtering. The final set contained 46 609 of 55 681 probes for the 5-month time point and 43 657 of 55 681 probes for the 10-month time point. A one-way ANOVA with a Benjamini and Hochberg false discovery rate correction factor of q 5 0.1 was used to find probes that significantly varied between the experimental groups. At 5 months of age, the dataset did not show any significant differences under these parameters; however, at 10 months of age, 28 probe sets were significantly different.
Because of the small sample size of our study, the FDR adjustment using q 5 0.05 was impractical; therefore we relied on immunofluorescence validation to determine the empirical false positive rate for our findings.
Gene ontology analysis
Gene ontology (GO) analysis was performed with the Biological Network for Gene Ontology (BiNGO) plugin (3.0.2) for Cytoscape (3.2.0) to identify the GO biological processes enriched (q 5 0.05) from the 28 differentially expressed genes in the 10-month-old TDP-43 A315T translational profile using a hypergeometric test with Benjamini and Hochberg correction (Maere et al., 2005) .
Immunohistochemistry with 3,3'-diaminobenizidine and immunofluorescence staining Mice were terminally anaesthetized by intraperitoneal injection of ketamine/xylazine (10 mg/10 g) and perfused transcardially firstly with phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , 1.47 mM KH 2 PO 4 , pH 7.4) and then 10% formalin (Sigma). Spinal cords were removed and post-fixed in the same fixative and embedded in paraffin blocks. Five micrometre sections or 3 mm for serial sections of paraffin-embedded mouse or human spinal cord were deparaffinized at 60 C for 20 min on a heat block and incubated in washes of xylene and xylene:ethanol (1:1), rehydrated through a series of graded alcohol washes (100-50%) and finally in water as previously described (Xiao et al., 2015a) . Antigen retrieval was carried out by pretreating the sections with TE9 buffer (10 mM Trizma Õ base, 1 mM EDTA, 0.05% Tween 20, pH 9.0), at 110 C in a pressure cooker for 15 min. For DAB (3,3'-diaminobenizidine) staining, after endogenous peroxidases were depleted with 3% H 2 O 2 for 10 min at room temperature, the slides were blocked with 2.5% normal horse serum (Vector Labs). Primary antibodies: rabbit anti-MTHFSD (AV40987, Sigma; 1:600); rabbit anti-TDP-43 (10782-2-AP, Proteintech; 1:20 000); rabbit anti-DDX58 (ab45428, Abcam; 1:400); rabbit anti-SOD1 exposed dimer interface (SEDI) [in-house (Rakhit et al., 2007) 
Sodium arsenite-induced stress in HeLa cells
HeLa cells were grown in Dulbecco's modified Eagle medium (DMEM; Gibco) supplemented with 10% foetal bovine serum. Cells were grown on coverslips in four-well plates (Nunc) to $80% confluency, then treated with 0.5 mM sodium arsenite (Sigma) at 37 C for 45 min or with PBS pH 7.4 (Life Technologies). For immunocytochemistry, HeLa cells grown on coverslips were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 10 min and subsequently permeabilized and blocked with 10% donkey, 3% bovine serum albumin, 0.3% Triton TM X-100 in PBS, then labelled as above. Microscopy was performed using Leica DM6000B and DMI6000B microscopes and images captured with Volocity 6.3 software (Perkin Elmer).
Construct design
EGFP-TDP-43
WT was subcloned into the mammalian expression vector pcDNA3.1(À), as previously described (Xiao et al., 2015b) . For generation of the TDP-43
A315T EGFP-tagged construct, 10 ng of EGFP-tagged TDP-43
WT plasmid DNA was amplified with 125 ng of forward primer, 5'-GTGGTGGGAT GAACTTTGGTACGTTCAGCATTAATCCAGCC-3'; and reverse primer, 5'-GGCTGGATTAATGCTGAACGTACCA AAGTTCATCCCACCAC-3', 200 mM dNTP and 2.5U of PfuUltra DNA polymerase with an initial denaturation at 
RNA immunoprecipitation
Neuro-2 a (N2a) cells maintained in DMEM supplemented with 10% foetal bovine serum were plated on 15 cm plates (Nunc) and grown to $85% confluency, before transiently transfecting with either EGFP, EGFP-TDP-43
WT , or EGFP-TDP-43 Lysates were centrifuged at 20 000g for 10 min at 4 C and 0.8 ml of the supernatant was collected and diluted with 3.2 ml of dilution buffer (0.025 M Tris, 0.15 M NaCl, 0.001 M EDTA, 5% glycerol; pH 7.4, with protease inhibitors). The diluted supernatants were then pre-cleared with magnetic agarose beads for 30 min at 4 C and precipitated using GFP-Trap Õ magnetic agarose beads (gtma-20, Chromotek) for 60 min at 4 C. After thorough washing with wash buffer (0.025 M Tris, 0.15 M NaCl, 0.001 M EDTA, 5% glycerol, 0.05% NP-40; pH 7.4, with protease inhibitors), beads were resuspended in 200 ml lysis buffer from the Absolutely RNA Õ Nanoprep Kit, vortexed vigorously, and incubated at room temperature for 10 min. The beads were magnetically separated and RNA was purified from the supernatant following the Absolutely RNA Õ NanoPrep kit instructions with on-column DNase treatment.
Immunoblotting
Standard methods for immunoblotting were used. Briefly, homogenates from either TRAP or RNA immunoprecipitation lysis buffers or wash buffers were electrophoresed on 10% (w/v) sodium dodecyl sulphate-polyacrylamide gels and transferred to polyvinylidene fluoride (PVDF) membranes, which were then blocked for 1 h at ambient temperature in TBS containing 5% (w/v) skimmed milk powder. Membranes were incubated overnight at 4 C with primary antibodies diluted in blocking solution as follows: mouse-anti EGFP (632569, Clontech; 1:2000); rabbit anti-RPL7 (NB100-2269, Novus Biologicals; 1:2000). Immunoblots were then washed with TBS containing 0.05% Tween 20 (TBST) and incubated for 1 h at ambient temperature with either anti-mouse horseradish peroxidase conjugated (NA931, VWR; 1:5000); or anti-rabbit HRP conjugated (NA934, VWR; 1:5000) antibodies diluted in blocking solution. Antibody labelling was visualized using Western Lightning Õ Plus ECL (Perkin Elmer).
Reverse transcription polymerase chain reaction
The cDNAs were synthesized using SuperScript Õ III Firststrand Synthesis System for reverse transcription polymerase chain reaction (RT-PCR) (18080-051, Life Technologies) with either random hexamers or oligo(dT) according to the manufacturer's instructions. One microlitre of template cDNA was added to GeneAmp Õ Fast PCR Mix (4362070, Life Technologies) with 10 mM of forward primer and 10 mM of reverse primer as follows; Tardbp forward, 5'-CAGAGCTT TTGCCTTCGTC-3', reverse, 5'-TGGATATATGCACGCTGA TTC-3'; Mthfsd forward, 5'-TTCCTGGTCTGGTTCTTGTG-3', reverse, 5'-CCTGAAACAGGTCTCCATTG-3'; Ddx58 forward, 5'-AGCTGACATTCGAGTGGTTG-3', reverse, 5'-GAT CTTTGGTTTAGGGTGTGG-3'; Ccl4 (QT0015461, QIAGEN). Amplification was achieved using a 9800 Fast Thermal Cycler (Applied Biosystems) with an initial denaturation at 95 C for 30 s, followed by 35 cycles (Tardbp and Mthfsd) or 38 cycles (Ddx58 and Ccl4) of denaturation at 95 C for 0 s, annealing at 56-58 C for 30 s and extension at 72 C for 30 s. The PCR products were analysed by electrophoresis on 1.5% (w/v) agaorse/ ethidium bromide gels.
Statistical analysis
One-way ANOVA using post hoc analysis with Turkey's multiple comparisons test was used for statistical analysis (Prism v6.0, GraphPad).
Results
Translational profiling of misregulated genes in motor neurons of TDP-43 A315T mice
To identify mRNAs that were differentially translated in motor neurons as a result of mutant TDP-43 A315T expression, we used the TRAP method coupled with microarray analysis using spinal cords from both 5-month-and 10-month-old TDP-43 A315T mice. Three mouse spinal cords were pooled for each of four technical replicates, giving a total of 12 mice for each group (four groups:
A315T 5 months and 10 months; ChatbacTRAP 5 months and 10 months; to give a total of 48 mice for the TRAP analysis). A flowchart of the experimental outline is summarized in Supplementary Fig. 1 . TDP-43 A315T mice develop age-dependent changes resembling ALS and express mutant TDP-43 at approximately three times endogenous TDP-43 levels (Swarup et al., 2011) . At 5 months of age, these mice are pathologically, biochemically and phenotypically similar to non-transgenic littermates with the exception of an increase in glial fibrillary acidic protein (Gfap) promoter activity in the CNS (Swarup et al., 2011) . By 10 months of age, these mice exhibit cytoplasmic aggregates of TDP-43, a reduction in the number of large calibre axons in L5 ventral roots, neuroinflammation (microgliosis and astrocytosis), and a decreased latency in the accelerating rotarod test (Swarup et al., 2011) . Translational profiles of choline O-acetyltransferase (ChAT)-positive spinal motor neurons were examined at 5 months of age, at the initiation of neuronal inflammation, and at 10 months of age, at the initiation of rotarod deficits, to examine age-dependent effects of abnormal TDP-43 on motor neuron degeneration (Swarup et al., 2011) .
Hemizygous TDP-43 A315T mice were crossed with homozygous ChatbacTRAP mice to generate ChatbacTRAP/ TDP-43 A315T and ChatbacTRAP littermates. We validated that EGFP expression was maintained in motor neurons of ChatbacTRAP/TDP-43
A315T and that the TRAP procedure produced high quality mRNA (RINs 5 8.0; Supplementary  Fig. 2 ). The translational profile from ChatbacTRAP/TDP-43 A315T mice at 5 months of age did not reveal any significant changes in translating mRNAs (data not shown). However, at 10 months of age, 28 genes were differentially expressed in ChatbacTRAP/TDP-43
A315T mice compared to ChatbacTRAP littermates (Table 1 ). Of these 28 candidate genes, eight were non-coding and 20 were coding. The TDP-43 A315T transgene showed a 2.7-fold increase in expression, which acted as an internal positive control since the mouse probe is homologous to human TDP-43 and corresponded with previous data that shows $3-fold increased expression of human TDP-43 in this mouse model (Swarup et al., 2011) .
The 10-month-old TDP-43 A315T translational profile was analysed to identify overrepresented Gene Ontology (GO) categories. Using the BiNGO plugin for Cytoscape, we identified 60 enriched GO terms (hypergeometric test with Benjamini-Hochberg correction P 5 0.05) (Supplementary Table 2 ). Interestingly, the majority of these GO terms were related to RNA metabolism, immune response, and regulation of cell cycle.
Validation of genes identified by TRAP analysis of 10-month-old TDP-43 A315T mice
Genes for validation from the 10-month-old TDP-43 A315T translational profile were selected based on 5 2-fold expression compared to non-transgenic littermates as these were more likely to show detectable changes at the protein level.
Of the 20 coding mRNAs that were identified, seven had a differential expression of 52: four were upregulated, which included human TARDBP, and three were downregulated (Table 1, highlighted) . Apart from TARDBP, the six remaining gene candidates were demonstrative of overrepresented GO categories identified by BiNGO; RNA metabolism: methenyltetrahydrofolate synthetase domain containing (Mthfsd), pescadillo homolog (Pes1); immune response: chemokine (C-C motif) ligand 4 (Ccl4), DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (Ddx58); and regulation of cell cycle (Pes1). From the BiNGO analysis, the remaining two genes, protein kinase inhibitor beta (Pkib) and prickle homologue 4 (Prickle4) were either represented in a broad GO category (negative regulation of catalytic activity) or were absent from the analysis due to limited information.
To validate the gene candidates at the protein level, double immunofluorescence was performed using the respective antibodies and neurofilament antibody (SMI32), to identify motor neurons of the ventral horn. Both of the candidates involved in immune response (CCL4 and DDX58) exhibited increased labelling in the cytoplasm of spinal cord motor neurons of 10-month-old TDP-43 A315T mice, consistent with microarray results (Fig. 1A and B) . PRICKLE4 was expressed in the cytoplasm and nucleolus of motor neurons of non-transgenic mice, and this staining was diminished in TDP-43 A315T motor neurons, also correlating with the microarray results ( Fig. 2A) . MTHFSD was expressed solely in motor neuron nuclei of non-transgenic mice; however, in 10-month-old TDP-43 A315T mice, there was reduced expression in motor neuron nuclei and, interestingly, appearance of cytoplasmic granules (Fig. 2B ).
There were limited commercial options for antibodies to PKIB and PES1 and we were unable to optimize staining conditions for either protein, and as such these proteins were not pursued for further study.
RNA-binding proteins DDX58 and MTHFSD are differentially expressed in ALS motor neurons
To test if the deregulated genes identified in motor neurons of TDP-43 A315T mice had relevance to ALS, immunohistochemical analysis was performed using antibodies against CCL4, DDX58, PRICKLE4, and MTHFSD in spinal cord of ALS and control cases. There were no apparent differences in CCL4 or PRICKLE4 immunoreactivity between control and sporadic ALS or familial ALS cases (data not shown); however, there was a marked increase in staining of DDX58 in motor neurons in both sporadic (non-c9-ALS) and familial forms of ALS (c9-ALS and SOD1-ALS), appearing diffusely throughout the cytoplasm (Fig. 3) . There was also labelling of small cytoplasmic speckles with DDX58 antibody, but no apparent labelling of inclusions (Fig. 3E) . In addition to these changes, there was also a clear labelling of astrocytes with DDX58 antibody in ALS cases versus controls (Fig. 3F) . In motor neurons of control cases, MTHFSD was localized to the nucleus, similar to the staining pattern observed in non-transgenic mice, with the addition of light-to-moderate staining of glial cell nuclei (Fig. 4A) . However, the staining patterns in motor neurons within and across ALS cases were highly variable. There were two distinct staining patterns of MTHFSD of motor neurons in ALS cases. In the first, and most common pattern, there was loss of MTHFSD staining in the nucleus with minimal staining in the cytoplasm (Fig.  4B ). In the second pattern, there was maintenance of nuclear staining with light to dark cytoplasmic staining (Fig. 4C) .
As TDP-43 pathology is a hallmark of ALS, using serial sections, we examined whether changes in MTHFSD were associated with TDP-43 pathology. The nuclear loss of MTHFSD coincided with loss of nuclear TDP-43 (Fig.  4B , D and E) but was also commonly depleted from the nucleus even when there was nuclear TDP-43 (Fig. 4D) . Quantitatively, the loss of nuclear MTHFSD staining was only significant in non-c9-ALS cases (Fig. 4I) . In most cases, MTHFSD did not stain cytoplasmic inclusions, with the exception of rarely co-localizing with hyaline conglomerate inclusions in SOD1 familial ALS cases ( Fig. 4F and G) . Additionally, MTHFSD was cytoplasmic in glial cells with variable intensity between cases (Fig. 4H) .
MTHFSD is a component of stress granules induced by oxidative stress
Although no literature has been published on the function of MTHFSD, the cytoplasmic staining in TDP-43 A315T mice highly resembled that of stress granules. Stress granule markers have been found to co-localize with TDP-43 in some cases of ALS and in multiple models of the disease (LiuYescevitz et al., 2010; Parker et al., 2012; Wolozin, 2012; Kim et al., 2014) . Additionally, MTHFSD contains a RRM domain, common among ALS-related proteins and components of stress granules (Li et al., 2013) . We investigated whether MTHFSD was able to assemble into stress granules under conditions of oxidative stress by treating HeLa antibodies, compared to non-transgenic littermates. These images are representative of findings from three to five spinal cord sections from three to four different mice from each genotype. Scale bar = 50 mm; inset scale bar = 25 mm. cells with 0.5 mM sodium arsenite for 45 min. We found that after treatment with sodium arsenite, MTHFSD partially co-localized with both TDP-43 and the stress granule marker Ras GTPase-activating protein-binding protein 1 (G3BP, encoded by G3bp1) (Fig. 5) ; however, we were unable to show that the granules labelled by MTHFSD antibody in motor neurons of 10-month-old TDP-43 A315T mice were co-labelled with antibodies to known stress granule markers [T-cell intracellular antigen 1 (TIA1), G3BP, polyadenylate-binding protein 1 (PABPC1) eukaryotic initiation factor 3 (eIF3, encoded by Eif3a) (data not shown)].
Ddx58 and Mthfsd are direct targets of TDP-43
Both MTHFSD and DDX58 were differentially expressed in TDP-43 A315T mice and revealed pathologicallyassociated changes in ALS cases. We therefore wanted to determine if TDP-43 bound to their corresponding mRNAs. Both Mthfsd and Ddx58 contain several (UG) 3 and (UG) 3-6 repeats, respectively, which are known binding motifs of TDP-43 (Buratti and Baralle, 2001; Kuo et al., 2009) ; however, neither have been identified by previous crosslinking and immunoprecipitation-sequencing (CLIPseq) (Polymenidou et al., 2011; Tollervey et al., 2011; Xiao et al., 2011) or RNA immunoprecipitation-sequencing (RIP-seq) (Sephton et al., 2011) (Fig. 6A ) using commercially available EGFP antibody covalently coupled to magnetic agarose beads (Fig. 6B) . RT-PCR of immunoprecipitates confirmed that TDP-43
WT and TDP-43 A315T bound to Mthfsd and Ddx58 mRNA, using mouse Tardbp as a positive control, but not with candidate Ccl4, which does not contain UGrich repeats (Fig. 6C) . 
Discussion
A hallmark feature of degenerating motor neurons in ALS is the mislocalization of TDP-43 from the nucleus to the cytoplasm, where it forms ubiquitinated inclusions (Arai et al., 2006; Neumann et al., 2006; Dickson et al., 2007; Geser et al., 2008; McCluskey et al., 2009; Mackenzie et al., 2010) . Although mutations in TDP-43 are a rare cause of ALS, TDP-43 pathology is present in the majority of ALS cases, suggesting that abnormalities of TDP-43 are important contributors to disease pathogenesis (Ling et al., 2013) . In this study, we coupled a disease-causing mutant Figure 3 Increased DDX58 immunoreactivity in motor neurons in ALS. (A and B) There was minimal labelling of DDX58 in motor neurons of controls cases, however, in ALS cases (C-E) there was increased labelling of DDX58 in the cytoplasm of motor neurons where it occasionally stained small granules (E, arrows). Of note, there was no apparent co-localization of DDX58 with cytoplasmic inclusions (E, arrowhead). (F) Cytoplasmic labelling of DDX58 was also noted in glial cells in ALS cases but not in controls. These images are representative of findings from three to five spinal cord sections from 16 ALS and four disease control cases. Scale bar = 10 mm (A-E), 20 mm (F).
TDP-43 transgenic mouse model with TRAP technology to identify age-dependent, motor neuron-specific translational changes as a consequence of abnormal TDP-43. First, we wanted to observe translational changes in TDP-43 A315T mice before the onset of functional motor neuron degeneration, to elucidate primary changes and minimize the identification of secondary effectors. At 5 months of age, these mice begin to exhibit neuroinflammation of the brain, 1-2 months before neuroinflammatory signs in the spinal cord (Swarup et al., 2011) . At this stage there was no significant difference between the translational profiles of ChatbacTRAP/TDP-43 A315T and ChatbacTRAP mice, suggesting that TDP-43 A315T mice are neurologically similar to non-transgenic in early/mid-adulthood, at least in regard to the translatome of spinal motor neurons. However, at 10 months of age, there was a significant difference in translational profile of ChatbacTRAP/TDP-43 A315T and ChatbacTRAP mice. At 10 months of age, the translational profile of TDP-43 A315T mice had overrepresented GO terms relating to immune response, regulation of cell cycle and RNA metabolism. Of the seven genes that met our criteria for validation, four corresponded to the microarray results at the immunohistochemical level in motor neurons of TDP-43 A315T mice (CCL4, DDX58, PRICKLE4, and MTHFSD). We were unable to validate PKIB and PES1 due to limitations in availability and/or optimization of antibodies. Of the four genes validated in the TDP-43 A315T mice, two were confirmed in ALS cases (DDX58 and MTHFSD). The lack of validation of CCL4 and PRICKLE4 in ALS cases may reflect differences between human and mouse motor neurons, especially in comparison with A315T transgenic mice where there is 2-3-fold overexpression of human TDP-43.
Two genes involved in immune regulation (Ccl4 and Ddx58) showed increased labelling in motor neurons of TDP-43 A315T mice. CCL4, also known as macrophage inflammatory protein 1-beta (MIP-1b) is a member of the C-C chemokine subfamily and its main function is to recruit leucocytes to the site of inflammation through -43 co-localize to the nucleus in healthy motor neurons (arrows). Across ALS cases there were two distinct staining patterns of MTHFSD. (B, D and E) MTHFSD was most commonly seen to be depleted from the nucleus with minimal cytoplasmic staining, while in the second pattern (C), there was maintenance of nuclear staining but with medium to dark cytoplasmic staining. (B and E) Loss of nuclear MTHFSD coincided with loss of nuclear TDP-43 (arrows); however, there were also instances where nuclear MTHFSD staining was lost while TDP-43 was primarily nuclear (C, arrows). MTHFSD did not stain TDP-43 positive cytoplasmic inclusions (E, arrow), however MTHFSD occasionally stained hyaline conglomerate inclusions identified by the SEDI antibody in SOD1-ALS (positively labelled in F but not in G, arrows). (H) MTHFSD was also present in the cytoplasm of glial cells in ALS but not control cases. Scale bar = 15 mm (A-H), 30 mm (H). (I) The loss of nuclear MTHFSD was significant in nonc9-ALS (n = 7) when compared to control (n = 4) (P 5 0.05); however, it was not significant in SOD1-ALS (n = 3) or c9-ALS (n = 6). Three to five sections and 5 30 motor neurons were examined per case. Data are mean AE SEM.
interaction with C-C chemokine receptor type 5 (CCR5) (Rossi and Zlotnik, 2000; Rostène et al., 2007) . Upregulation of CCL4 has been shown in a number of neurological disorders including brain injury (Shea et al., 2013) , epilepsy (Lukasiuk et al., 2006; Choi et al., 2009) , HIV-associated dementia (Glass et al., 1995; Schmidtmayerova et al., 1996; Kelder et al., 1998; Minagar et al., 2002 ), Alzheimer's disease (Xia et al., 1998; Xia and Hyman, 1999; Minagar et al., 2002) , and in models of nerve injury (Gamo et al., 2008) , although, its cell-type localization in the CNS (neuronal versus glial) and whether or not it is neurotoxic (Yates et al., 2000; Choi et al., 2009; Zhu et al., 2014) or neuroprotective (Kaul and Lipton, 1999; Kaul et al., 2007; Gamo et al., 2008; Tateishi et al., 2010) in disease have been widely reported in the literature. Interestingly, an increase in CCL4 in CSF has been shown to negatively correlate with progression of ALS suggesting that CCL4 may be neuroprotective; however, in this study, CCL4 was not detected in control or ALS spinal cord (Tateishi et al., 2010) .
There was a decrease in labelling of PRICKLE4 in the cytoplasm and the nucleolus in motor neurons in TDP-43 A315T mice; however, there were no observable differences in expression between ALS and control motor neurons. PRICKLE4 is a member of the Prickle family, which function in the non-canonical Wnt signalling pathway, regulating intracellular calcium release and planar cell polarity (Tree et al., 2002; Veeman et al., 2003) . The most commonly described Prickle proteins, PRICKLE1 and PRICKLE2 are involved in axonal guidance, dendritic morphogenesis and synaptic plasticity (Tao et al., 2011; Liu et al., 2013) ; however, PRICKLE4 is structurally different from other Prickle family members as it contains two, instead of three LIM domains. The three LIM domains have been shown to function as part of the protein's tertiary structure required for interaction with its target proteins (i.e. Dishevelled) and membrane localization (Sweede et al., 2008) , therefore the exact function of PRICKLE4 is difficult to elucidate. DDX58, also known as retinoic acid inducible gene-I (RIG-I), is an RNA helicase that acts as a cytoplasmic receptor that recognizes viral double stranded RNA and initiates an innate immune response through mitochondrial antiviral signalling (MAVS) (Yoneyama et al., 2004) . Recently, DDX58 has been demonstrated to interact with host cellular RNAs (Malathi et al., 2007) and shown to be upregulated in chronic inflammatory diseases including atypical Singleton-Merten syndrome (Jang et al., 2015) , psoriasis (Tsoi et al., 2012) , dermatomyositis (Suá rezCalvet et al., 2014), multiple sclerosis (Enevold et al., 2009; Varzari et al., 2014) , and Alzheimer's disease (de Rivero Vaccari et al., 2014) . Interestingly, DDX58 signalling is upstream of TANK-binding kinase 1 (TBK1) (Yoneyama et al., 2004; Seth et al., 2005) , which has recently been associated with familial ALS through loss of function mutation(s) (Freischmidt et al., 2015) . It has been hypothesized that DDX58 signalling may be activated by small self-RNA cleavage products from damaged tissue (Malathi et al., 2007; de Rivero Vaccari et al., 2011 . In this study, we found that DDX58 showed increased labelling specifically in the motor neurons of TDP-43 A315T mice, which was also apparent in the motor neurons and surrounding glial cells in sporadic and familial ALS spinal cords compared to control. Previously, DDX58 was shown to be upregulated in motor neurons of SOD1 G93A mice, but downregulated in spinal cord motor neurons in sporadic ALS compared to controls (Kudo et al., 2010) . This discrepancy may be ALS-case specific, although it may be due to difference in the detection capability of the antibodies used, as glial staining was not reported in the earlier study, which is common in other neurological pathologies including Alzheimer's disease and models of spinal cord injury (de Rivero Vaccari et al., 2011 . Previous reports have shown that DDX58 signalling is involved in astrocyte activation (de Rivero Vaccari et al., 2011 . In ALS, upregulation of DDX58 may therefore suggest initiation of innate immunity in response to extracellular debris generated by degeneration, and/or promote glial activation and proliferation. MTHFSD was shown to have a different subcellular localization in spinal cord motor neurons of TDP-43 A315T mice compared to non-transgenic mice, where nuclear staining was reduced along with staining of cytoplasmic granules. Although the function of MTHFSD is unknown, it contains a methenyltetrahydrofolate synthase domain and an RRM domain. Methenyltetrahydrofolate synthase (MTHFS), which is in the same family as MTHFSD, regulates carbon flow in folate-dependent one-carbon metabolism required for the synthesis of purines, thymidylate nucleotides and for remethylation of homocysteine to methionine in the cytoplasm by converting the stable, storage form of folate to a metabolically active form, with MTHFS deficiency resulting in seizures, speech delay, and recurrent infections (Scaglia and Blau, 2013) . In ALS, there is an increase of homocysteine in the CSF and in astrocytes in mouse models of ALS where it is hypothesized to contribute to neuronal damage via excitotoxicity (Zhang et al., 2008; Valentino et al., 2010) . If the MTHFS-domain in MTHFSD is functionally similar to MTHFS, then MTHFSD downregulation or loss of function may contribute to increased homocysteine levels in the CNS, however, in healthy motor neurons, we observed MTHFSD to be primarily nuclear therefore it is difficult to speculate its function in this respect.
Although typically nuclear, MTHFSD was found in cytoplasmic granules in motor neurons of TDP-43 A315T mice, which we hypothesized to be stress granules as MTHFSD contains an RRM domain and stress granules markers have been found to co-localize with TDP-43 positive aggregates in ALS and in several models of the disease (Liu-Yescevitz et al., 2010; Bentmann et al., 2012; Dewey et al., 2012; Kim et al., 2014) . We were unable to label for stress granules in A315T motor neurons in vivo after trying several markers; however, after acute treatment with sodium aresenite, MTHFSD partially co-labelled with G3BP in HeLa cells identifying MTHFSD as a novel stress granule marker. There was no apparent co-labelling of TDP-43-positive inclusions with MTHFSD antibody in ALS cases. On the other hand, we have shown that MTHFSD partially co-labels with misfolded SOD1 in SOD1 familial ALS, therefore it is possible for MTHFSD to be involved with aggregated proteins involved in ALS.
To summarize, we have used translational profiling of motor neurons of a mutant TDP-43 transgenic mouse model to uncover gene ontologies related to ALS pathogenesis. Through this approach we have identified MTHFSD and DDX58 as novel RNA targets of TDP-43 that are deregulated both in motor neurons of TDP-43 A315T mice and ALS spinal cord. Both DDX58 and MTHFSD are RNA-binding proteins, further implicating abnormalities of RNA metabolism as a pathogenic process in ALS. This is supported by our finding of MTHFSD as a novel stress granule marker. Future studies will be aimed at elucidating the roles, either contributory or neuroprotective, of DDX58 and MTHFSD in ALS.
